Image

Newsroom

July 10, 2019

Mercyhealth Partners With Monarch Medical Technologies to Optimize Inpatient Diabetes Management

Mercyhealth, a multi-regional healthcare system serving northern Illinois and southern Wisconsin, is partnering with Monarch Medical Technologies to improve care for patients with diabetes or stress-induced hyperglycemia.
June 17, 2019

Monarch Medical Technologies and Voluntis to Host Webinar on Use of Technology to Support Inpatient and Outpatient Insulin Management

Monarch and Voluntis are partnering to offer a complimentary webinar, “How Technology Can Support Adoption of Best Practices for Inpatient and Outpatient Insulin Management.”
June 7, 2019

Monarch Medical Technologies Announces New Insulin-on-Board Adjustment for Subcutaneous Insulin Dosing

The company has obtained an additional clearance for an optional insulin-on-board (IOB) calculation to mitigate the risk of low glucose values as a result of residual rapid-acting insulin.
June 4, 2019

Monarch Medical Technologies to Participate in American Diabetes Association 79th Scientific Sessions and DiabetesMine D-Data ExChange

Monarch will be participating in the DiabetesMine D-Data ExChange on June 7, 2019 and the American Diabetes Association’s 79th Scientific Sessions on June 7-11, 2019 in San Francisco, CA.
April 29, 2019

Retrospective Analysis Produced by Monarch Medical Technologies Explores Effect of Blood Glucose Goal Range and Two-Hour Blood Glucose Checks on Hypoglycemia Incidence

The two studies analyze a database of nearly one million blood glucose readings from approximately 45,000 patients who were prescribed intravenous insulin dose recommendations using the EndoTool® Glucose Management System.
January 22, 2019

Monarch Medical Technologies Appoints Expert in Pediatric Diabetes, Dr. Mark Vanderwel, to Medical Advisory Board

Joining a board of diabetes experts, Dr. Vanderwel will bring expertise in pediatric endocrinology to support Monarch in the continual advancement of the EndoTool® Glucose Management System.
August 28, 2018

Monarch Medical Technologies Granted U.S. Patent for Approach to Inpatient Insulin Therapy

The U.S. Patent and Trademark Office (USPTO) has issued a new patent allowance, “Systems and Methods for Determining Insulin Therapy for a Patient,” describing unique methods and systems for more individualized insulin therapy in the inpatient setting.
August 15, 2018

Monarch Medical Technologies Expands Medical Advisory Board with Addition of Diabetes Experts

Drs. Carlos Mendez and Brian Ulmer join a roster of medical experts to support the company in delivering individualized insulin dosing for improved inpatient diabetes management.
June 20, 2018

Monarch Medical Technologies and Voluntis Announce Partnership to Provide Seamless Solution for Insulin Dosing Across the Continuum of Care

Providers can bridge the gap between inpatient and outpatient glycemic management with Monarch’s EndoTool® Glucose Management System and Voluntis’ Insulia®
May 16, 2018

Monarch Medical Technologies Hosts Webinar on Role of Nurses in Inpatient Diabetes Care

Presenter Jane Jeffrie Seley, Program Manager of Inpatient Glycemic Control Program at NewYork-Presbyterian Hospital/Weill Cornell Medicine, will focus on strategies to engage nursing staff in glycemic management practices.
February 7, 2018

Monarch Medical Technologies Announces Self-Service Analytics, Expansion of EndoTool Analytics Offering

The new module enables clients to further mine patient data and identify larger trends in clinical outcomes and processes using existing analytics tools and infrastructure.
January 30, 2018

Monarch Medical Technologies Hosts Webinar on Adoption of Inpatient Basal/Bolus/Correction Subcutaneous Insulin Therapy

The company will host a complimentary webinar, “Beyond Sliding Scale: Closing the Gap Between Current and Optimal Glycemic Management Practices.”
August 30, 2017

Monarch Medical Technologies Announces Laurel Fuqua as Executive Vice President and Chief Clinical Officer

Fuqua will lead the overall clinical vision, providing input into product strategy and working closely with customers on adoption and optimization of the EndoTool® platform.
May 18, 2016

Hypoglycemia From Residual Insulin – Ever Heard of It?

New technology from Monarch Medical Technologies statistically eliminates severe hypoglycemia in hospital glucose management.
September 1, 2015

Monarch Medical Technologies Shifts Market with Safest Insulin Therapy Treatment

Monarch has achieved a 30 percent growth in total installed sites, an increase in go‐lives by seven times, a five‐fold increase in sales, a second FDA 510(k) clearance for EndoTool SubQ, and a 40 percent increase in new personnel.